“Statistically significant improvements in lung function, symptoms and quality of life 36% reduction in rate of exacerbations over 24 weeks Well tolerated safety profile over 48 weeks NDA submission planned for 1H 2023” Oh, 48 weeks! !

there could be a cure/preventative for breast cancer out there

They have a great product treating cancer with immunotherapy, peer reviewed journal

Alzheimer therapies are on the top of choices.

A drug that actually helps without any major side effects .. and breakthrough therapy. .

Better than chemo.

$AVXL The oral Anavex 2-73 therapy met the primary and secondary endpoints of the trial, with patients receiving the therapy experiencing statistically significant improvement in cognition.

$TGTX MOST CONVENIENT- 50% faster infusion SAFEST - Zero Breast Cancer Risk MOST AFFORDABLE - By far If TGTX was a Big Pharma Company, the medical press would be blowing it up with praise.

INFUSION TIME 3.NO BREAST CANCER ISSUES 4.

- Lowest ARR rate, no black box label, reduced brain lesions, and no reports of breast cancer.

Lowest ARR rate, no black box warning label, reduced brain lesions, and no reports of breast cancer (there are reports of breast cancer with other MS treatments, and 75% of people with MS are women).

$TGTX "4 Stories of Living with Multiple Sclerosis" Briumvi, the best and most affordable, 1HR infusion, no black box label warning, and no warning or report of causing breast cancer.

No breast cancer risk.

Major upgrade for patients and infusion centers -No major health threats like breast cancer or sever liver damage like main competition

$TGTX possibly the best therapy available for MS patients that exists today!

MS is 3 times more common in women and there were no reports of breast cancer compared to the competition!

These patients experienced about 35% longer survival than has been reported for other second-line therapies.

* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.

* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.

* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.

Good cancer stock from what I hear in 2028.

$MRK Ovarian cancer data final P2 results are better than any other drugs by a mile.

They address a broad range of cancer indications.

$SLS Gps arm 22 months of median Overall Survival Best Available Therapy 8.

$SLS In addition to GPs FDA approval for AML secondary Remission patients - Gps + Keytruda/Checkpoint Inhibition is also best in class for Ovarian cancer patients.

The nation’s best means the O'Neal Comprehensive Center in Alabama have access to the latest therapies, cutting-edge clinical trials and the expertise needed to treat their cancer.